Jordan D Berlin

16PUBLICATIONS
151CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsOncology and carcinogenesis not elsewhere classifiedCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jun 30, 2025
A First-in-Human Study of Givastomig, a CLDN18.2 and 4-1BB Bispecific Antibody, as Monotherapy in Patients with CLDN18.2-Positive Advanced or Metastatic Solid Tumors.

Geoffrey Ku, Lin Shen, Farshid Dayyani

|Feb 10, 2025
Results of the Phase I/II Study and Preliminary B-cell Gene Signature of Combined Inhibition of Glutamine Metabolism and EGFR in Colorectal Cancer.

Kristen K Ciombor, Seong-Woo Bae, Jennifer G Whisenant

|Aug 08, 2024
Management of Locally Advanced Rectal Cancer: ASCO Guideline.

Aaron J Scott, Erin B Kennedy, Jordan Berlin

|Jun 30, 2023
Factors and Barriers to Goals-of-Care Conversations for Patients With Cancer and Inpatient Mortality.

Margaret Wheless, Julie J Lee, Henry J Domenico

|Jan 20, 2023
National Cancer Institute Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH).

Funda Meric-Bernstam, James M Ford, Peter J O'Dwyer

|Dec 15, 2022
Adjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial.

Margaret A Tempero, Uwe Pelzer, Eileen M O'Reilly

Pageof 3

Frequent Collaborators

3 joint publications

Erin B Kennedy

2 joint publications

Annick Seithel-Keuth

2 joint publications

Anthony J Olszanski

2 joint publications

Dana Backlund Cardin